Supporting Older Adults Remotely
Public ClinicalTrials.gov record NCT07878169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Supporting Older Adults Remotely (SOAR): Protocol for a Type 1 Hybrid Effectiveness-Implementation Randomized Controlled Trial of a Certified Older Adult Peer Specialist Intervention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Supporting Older Adults Remotely (SOAR) study is a randomized controlled trial evaluating a 12-week, telephone-delivered peer support intervention for adults age 50 and older with serious mental illness who live in supportive housing. SOAR is designed to support aging in place and improve independent living skills through structured peer support focused on medication adherence, medical and psychiatric self-management, coping, goal setting, healthcare navigation, social relationships, self-advocacy, and connection to community resources. Participants will be randomly assigned to receive either SOAR or Peer Support as Usual. Participants will complete assessments at baseline and 3, 6, and 12 months. The study will also examine factors that may help or hinder implementation and sustainability of SOAR in supportive housing.
Study identification
- NCT ID
- NCT07878169
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Supporting Older Adults Remotely (SOAR) Behavioral
- Peer support as usual Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2026 (Estimated)
- Primary completion
- Dec 1, 2028 (Estimated)
- Completion
- Dec 1, 2028 (Estimated)
- Last update posted
- Oct 16, 2026
2026 – 2028
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Bridge | New York | New York | 10027 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07878169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2026 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07878169 live on ClinicalTrials.gov.